Walleye Capital
CMND icon

Walleye Capital’s Clearmind Medicine CMND Stock Holding History

Walleye Capital’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$61.7K – 4997
2023
Q3 		$61.7K Buy
+4
New +$147K ﹤0.01% 4124
2023
Q1 		– Hold
0
– -$140K – 3979
2022
Q4 		– Hold
0
– – – 2242

Other funds holding CMND

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Walleye Capital's CMND Position: Q4 2023 in Review

Walleye Capital sold out of Clearmind Medicine (CMND) in Q4 2023, closing a stake of 4 shares — an estimated $61.7K sold.

Walleye Capital first reported a position in CMND in Q3 2023 and held it in 1 quarter. The position peaked at $61.7K in Q3 2023. 1 fund tracked by Wall St. Rank holds CMND as of Q4 2023.

  • Walleye Capital reported no remaining Clearmind Medicine position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 4 Clearmind Medicine shares in Q4 2023, an estimated $61.7K.
  • Walleye Capital first reported a position in Clearmind Medicine in Q3 2023 and held it in 1 quarter.
  • Walleye Capital's Clearmind Medicine position peaked at $61.7K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Clearmind Medicine as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.